a major mucin secreted from the goblet cells of the surface epithelium (15) . MUC5AC mRNA is predominantly expressed in surface goblet cells (16) and is regarded as a marker for goblet cell metaplasia in murine airways (17) . The number of goblet cells in airway tissue markedly increases in patients with bronchial asthma (12), and the MUC5AC mRNA level has been reported to increase in the bronchial tissue of patients with mild or moderate asthma (18) . These observations strongly suggest that increased expression of the MUC2 and MUC5AC genes contributes to mucus hypersecretion in patients with chronic airway diseases.
Consequently, since HAT was purified from the sputum of patients with airway mucus hypersecretion, it is possible that HAT is involved not only in airway inflammation, but also in mucus hypersecretion. Therefore, in this study, the effect of HAT on both mucin production and gene expression in vitro was examined in the mucin-producing airway epithelial cell line NCI-H292, which is often used as a model system for mucin production (Reviewed in Ref 19) . Additionally, since little is known about the role of PAR-2 in airway mucin production, the PAR-2 agonist peptide (PAR-2 AP) was used to examine the contribution of PAR-2 to mucus hypersecretion. Moreover, involvement of epidermal growth factor receptor (EGFR) was also evaluated, because EGFR has been shown to play an important role in induction of mucin gene expression or mucin production in NCI-H292 cells (20, 21, 22, 23, 24, 25) .
(Minneapolis, MN).

Cell Culture
The human pulmonary mucoepidermoid carcinoma cell line NCI-H292 was purchased from American Type Culture Collection (Rockville, MD) and cultured in RPMI-1640 medium supplemented with 10% (v/v) FBS, 50 U/ml penicillin, and 50 µg/ml streptomycin (Gibco BRL; Grand Island, NY) in a humidified incubator at 37°C in an atmosphere of 5% CO 2 : 95% air. Before experiments, confluent NCI-H292 cells were cultured in serum-free medium (SFM; RPMI-1640 medium containing only 0.1% (w/v) BSA (Sigma)) for 24 hours, unless otherwise indicated. Human lung carcinoma cell line A549 cells were also obtained from ATCC and cultured in DMEM containing 10% FBS, 50 U/ml penicillin, and 50 µg/ml streptomycin (Gibco BRL) under the same conditions used for NCI-H292 cells.
Assessment of Cell Viability
Cell viability was determined by measuring metabolic activity of the cells using fluorogenic, oxidation-reduction indicator Alamar Blue TM (Biosource International;
Camarillo, CA) after undergoing treatment with proteases. Serum-depleted NCI-H292 cells were treated for 24 hours with HAT or other protease dissolved in SFM. The control group comprised cells treated with SFM that did not contain a protease. At the end of treatment, a volume of Alamar Blue TM equal to 1/10 the culture medium volume was added to the medium, and 2 hours later, a CytoFluor 2300 fluorometer (Millipore; Bedford, MA) was used to measure fluorescence at 590 nm after excitation at 560 nm.
Measurement of Intracellular Ca 2+ Mobilization
Three thousand NCI-H292 cells were seeded onto glass-bottom culture dishes Tokyo, Japan) was used to monitor the ratio of Fura-2 fluorescence at 510 nm after excitation, first at 340 nm, and then at 380 nm.
For each sample of cells, an RNeasy Mini Kit (QIAGEN; Hilden, Germany), which included a DNase I digestion step (RNase-free DNase set, QIAGEN), was used to extract total cellular RNA. Approximately 0.5 µg of each total RNA preparation was reverse-transcribed with Omniscript RT (QIAGEN), and random hexamers were used to prime the reactions. These synthesized cDNA samples were separately diluted 5-fold with nuclease-free water, and 2 µl of each diluted cDNA solution was used as the template in a 20 µl Hotstar-Taq PCR master reaction mix, with specific primers and conducted according to the manufacturer's protocol (QIAGEN). The primers used for PAR-2 (Gene Bank Accession No.: U34038) mRNA detection were forward primer:
5'-TGGATGAGTTTTCTGCATCTGTCC-3', and reverse primer: 5'-CGTGATGTTCAGGGCAGGAATG-3'. The primers used for detecting the β-actin (Gene Bank Accession No.: BC014861) internal control mRNA were forward primer:
5'-CAAGAGATGGCCACGGCTGCT-3', and reverse primer:
5'-TCCTTCTGCATCCTGTCGGCA-3'. To ensure that the product resulted from reverse transcription, mock reactions that did not contain reverse transcriptase were conducted.
Real-Time RT-PCR to Quantitate Mucin and Amphiregulin mRNA
A GeneAmp 5700 sequence detection system (Applied Biosystems; Foster City, CA) to conduct real-time RT-PCR was used to measure MUC2 and MUC5AC mRNA expression. Extraction of total cellular RNA and synthesis of cDNA were performed as described in the previous section. PCR was performed using a TaqMan TM Universal 
Determination of AR protein
AR protein in the culture supernatant from NCI-H292 treated with vehicle, HAT or PAR-2 AP were measured using a commercial, specific ELISA kit according to the manufacturer's instruction. The limit of assay sensitivity is 25.6 pg/ml. 
Statistical Analysis
Results
HAT Activates PAR-2 in NCI-H292 Cells
Since the expression of PAR-2 by NCI-H292 has not been reported, reverse transcription-PCR (RT-PCR) was used to test whether these cells express PAR-2 mRNA.
As shown in (Fig. 1D ).
These results demonstrate that functional PAR-2 is expressed by NCI-H292 cells, and that HAT also can activate PAR-2 in these cells.
Induction of Mucous Glycoconjugate Production and Mucin Gene Expression
To evaluate the possibility that HAT enhances mucin production, the effect of HAT on mucous glycoconjugate production in NCI-H292 cells was examined. As Fig. 2A shows, few vehicle-treated cells were stained by AB-PAS staining. However, the number of AB-PAS positive cells and the intensity of AB-PAS staining in each cell clearly increased after treatment with either the test protein HAT (Fig. 2B ), or the positive control EGF ( Since EGF has been reported to increase MUC2 and MUC5AC gene expression (20) , this increase in mucus production is thought to be accompanied by enhancement of mucin gene expression. To determine whether HAT increases mucin gene expression, the effect of HAT on MUC2 and MUC5AC mRNA level was examined using real-time RT-PCR (Fig. 2E ).
HAT treatment induced a 23-fold increase in MUC2 mRNA level and a 32-fold increase in MUC5AC mRNA level. EGF treatment also increased the MUC2 mRNA level 16-fold and the MUC5AC mRNA level 6-fold in this study, in accordance with a previous observation (20) . In contrast, PAR-2 AP treatment did not significantly change basal MUC2 and MUC5AC mRNA levels. These results show that both HAT and EGF increase mucin gene expression, and together with the staining experiments suggest that increased mucin gene expression leads to increased production of MUC2 and MUC5AC proteins.
Time Course and Dose Response to HAT Treatment
Since the MUC5AC is one of the mucin genes most active in patients with chronic airway diseases, and because it is thought to be a marker for goblet cell metaplasia (17, 18) , the effect of HAT on MUC5AC gene expression was examined in detail. As Fig. 3 shows, HAT increased the MUC5AC mRNA levels in NCI-H292 cells in a time-dependent (Fig. 3A) and concentration-dependent (Fig. 3B) manner. In the HAT treated cells, MUC5AC mRNA levels significantly increased to 5 times greater than the basal level by 8 hours after the onset of treatment and continued to increase steadily, until the last time point at 24 hours after the onset of treatment. EGF also increased the MUC5AC mRNA level in a time-dependent manner. In contrast to the HAT results, the MUC5AC mRNA level in the EGF-treated cells started to increase significantly faster (after treatment for only 4 hours) than in HAT-treated cells (Fig. 3A) .
As Fig. 3B shows, a significant HAT-induced increase of MUC5AC mRNA levels, compared with vehicle-treated cells, was observed at an HAT concentration as low as 20 nM. Table 1 The PAR-2 AP used in the present study is thought to be biologically active, because it evoked intracellular Ca 2+ mobilization in NCI-H292 cells (Fig. 1B, D) . These results suggest that activation of PAR-2 alone is neither sufficient nor directly involved in the regulation of MUC5AC gene expression.
HAT Protease Activity is Required for Increased MUC5AC Gene Expression
Some proteases are known to express their function through nonproteolytic actions in addition to their function through proteolysis (27). To clarify whether the stimulatory effect of HAT on MUC5AC gene expression is caused by its proteolytic activity alone, the effect of serine protease inhibitors on HAT-induced MUC5AC gene expression was examined. As shown in Fig. 4A , both leupeptin and aprotinin, which are potent inhibitors of HAT trypsin-like activity (1), markedly reduced the HAT-induced increase of MUC5AC mRNA levels, whereas they showed no significant effect on either basal MUC5AC mRNA levels or on the EGF-induced increase of MUC5AC levels (Fig.   4A ). Moreover, heat inactivation of HAT by boiling almost completely destroyed its ability to increase MUC5AC mRNA levels (Fig. 4A) . These results indicate that HAT-induced MUC5AC gene expression is caused by the proteolytic activity of HAT.
Since MUC5AC gene expression is modulated by HAT, the ability of other serine proteases to induce MUC5AC gene expression was examined (Fig. 4B ).
Neutrophil elastase, an inflammatory mediator present at high concentration in airway tissue from patients with bronchitis, has been reported to increase MUC5AC mRNA levels in the A549 carcinoma cell line and primary human bronchial epithelial cells taken from healthy subjects (28); it has also been reported to increase MUC5AC
protein production in the NCI-H292 cells used in this study (21) . As expected, leukocyte elastase at concentration of 100 nM increased MUC5AC mRNA levels in NCI-H292 cells. In contrast, lung mast cell tryptase, a major trypsin-like protease found in airway tissue, did not affect MUC5AC mRNA levels. These results indicate that HAT, like leukocyte elastase, is an important serine protease that regulates MUC5AC gene expression during the course of chronic airway diseases.
The Effect of EGFR Inhibitors and Neutralizing Antibodies to EGFR Ligands on HAT-Induced MUC5AC Gene Expression
The cellular mechanism responsible for HAT-induced MUC5AC gene expression was examined. Activation of epidermal growth factor receptor (EGFR) is one of the best known mechanisms responsible for regulation of mucin production and mucin gene expression in NCI-H292 cells (20, 21, 22, 23, 24, 25) . The results of the present study showed that both EGF and HAT increase expression of the MUC2 and the MUC5AC genes; in addition, HAT increases viable cell number, indicating that HAT enhances growth of the cells. These observations strongly suggest HAT activates EGFR.
To test whether HAT-induced MUC5AC gene expression is mediated by activation of EGFR, AG1478, a potent and selective chemical inhibitor of EGFR tyrosine kinase activity, and an anti-EGFR neutralizing antibody were used to block EGFR signal transduction. As expected, pretreatment (20 minutes) with either AG1478 or the anti-EGFR neutralizing antibody inhibited the EGF-induced increase of MUC5AC mRNA levels (Fig. 5A) . Furthermore, the effect of HAT was also completely disrupted by pretreatment with these EGFR inhibitors. Since anti-EGFR neutralizing antibody From these observations, it is possible that HAT exists at a sufficient level to enhance mucin production in the mucoid sputum from patients with chronic airway diseases and is involved in airway mucus hypersecretion.
The next question addressed was that of the target of HAT activity. In a previous study, HAT was shown to activate PAR-2 in primary bronchial epithelial cells (6). Although the functional PAR-2 is expressed in NCI-H292 cells, PAR-2 AP could not induce either mucin production or mucin gene expression in these cells, during the present study (Fig. 2, 3) . Results from control experiments show that this batch of PAR-2 AP was biologically active; it initiated intracellular Ca 2+ mobilization in NCI-H292 cells (Fig. 1B, 1D ). In addition, tryptase, which is known to activate PAR-2 (5), did not show any effect on MUC5AC mRNA levels in NCI-H292 cells (Fig. 4B) . results of the present study show that the HAT-mediated increase of MUC5AC mRNA levels occurs later than that of EGF (Fig. 3A) . A study to delineate in detail the mechanism by which HAT induces AR gene expression is now under way. Although results from the present study suggest that PAR-2 AP does not affect mucin production, it has been reported that PAR-2 AP stimulates secretion of mucin in the rat stomach (5, 35) . This observation suggests that PAR-2 might regulate mucin secretion from, rather than mucin production by airway tissue, and that HAT might have a dual action in airway mucin regulation: increasing mucin production through the AR-EGFR pathway, and enhancing mucin secretion through a PAR-2-mediated pathway. Further studies are necessary to examine biochemical and morphologic changes in the airway tissue of HAT-treated animals and to clarify roles of HAT in the pathogenesis of chronic airway 23 diseases such as chronic bronchitis and bronchial asthma.
In conclusion, the results of this study show that HAT regulates mucin gene expression in the NCI-H292 airway epithelial cell line, through an AR-EGFR pathway.
In addition, results of previous studies suggest that HAT is involved in airway inflammation mediated by PAR-2. 
